<SEC-DOCUMENT>0001213900-21-033346-index.html : 20210621
<SEC-HEADER>0001213900-21-033346.hdr.sgml : 20210621
<ACCEPTANCE-DATETIME>20210621170030
ACCESSION NUMBER:		0001213900-21-033346
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20210616
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210621
DATE AS OF CHANGE:		20210621

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aditx Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001726711
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				823204328
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39336
		FILM NUMBER:		211031562

	BUSINESS ADDRESS:	
		STREET 1:		2569 WYANDOTTE, ST.
		STREET 2:		SUITE 101
		CITY:			MOUNTAIN
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		909-488-0844

	MAIL ADDRESS:	
		STREET 1:		2569 WYANDOTTE, ST.
		STREET 2:		SUITE 101
		CITY:			MOUNTAIN
		STATE:			CA
		ZIP:			94043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADiTx Therapeutics, Inc.
		DATE OF NAME CHANGE:	20171229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea142958-8k_aditxtherap.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea142958-8k_aditxtherap.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea142958ex99-1_aditx.htm
<DESCRIPTION>PRESS RELEASE, DATED JUNE 17, 2021
<TEXT>
Document 2 - file: ea142958ex99-1_aditx.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ea142958ex99-2_aditx.htm
<DESCRIPTION>LEAD INDEPENDENT DIRECTOR CHARTER
<TEXT>
Document 3 - file: ea142958ex99-2_aditx.htm

</DOCUMENT>
</SEC-DOCUMENT>